Encephalitis caused by hepatitis A vaccine

Original source

1. [1]
   Immunogenicity and safety of hepatitis A vaccine at different vaccination intervals among adults aged 18 years and above: Interim results. — Chang L, Li Z, Liu Y, Fei S, Zhao L, Li J et al. Human vaccines & immunotherapeutics (2025)
2. [2]
   Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review. — Gurav YK, Bagepally BS, Thakkinstian A, Chaikledkaew U, Thavorncharoensap M The Indian journal of medical research (2022)
3. [3]
   Evidence of Circulation of Several HAV Genetic Variants and Emergence of Potential Antigenic Variants in an Endemo-Epidemic Country before Vaccine Introduction. — Ayouni K, Chouikha A, Khamessi O, Touzi H, Hammemi W, Triki H Viruses (2021)
4. [4]
   Hepatitis a virus vaccine escape variants and potential new serotype emergence. — Pérez-Sautu U, Costafreda MI, Caylà J, Tortajada C, Lite J, Bosch A et al. Emerging infectious diseases (2011)
5. [5]
   Virosomal hepatitis a vaccine: comparing intradermal and subcutaneous with intramuscular administration. — Frösner G, Steffen R, Herzog C Journal of travel medicine (2009)
6. [6]
   Use of hepatitis A vaccine in a community-wide outbreak of hepatitis A. — Craig AS, Sockwell DC, Schaffner W, Moore WL, Skinner JT, Williams IT et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (1998)
7. [7]
   Prevention of hepatitis A and B. — Bell S, Watson K Australian family physician (1997)
8. [8]
   Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports (1996)
9. [9]
   New developments in hepatitis A control. — Yuan L Canadian family physician Medecin de famille canadien (1995)
10. [10]
    Public health control of hepatitis A: memorandum from a WHO meeting. Bulletin of the World Health Organization (1995)
11. [11]
    Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later. — Briem H, Safary A Journal of medical virology (1994)
12. [12]
    Possible approaches to develop vaccines against hepatitis A. — D'Hondt E Vaccine (1992)
13. [13]
    Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine. — Theilmann L, Kallinowski B, Gmelin K, Hofmann F, Scheiermann N, Wohland B et al. Vaccine (1992)
14. [14]
    Development of live, attenuated hepatitis A vaccine (H2-strain). — Mao JS Vaccine (1990)
15. [15]
    An inactivated hepatitis A viral vaccine of cell culture origin. — Provost PJ, Hughes JV, Miller WJ, Giesa PA, Banker FS, Emini EA Journal of medical virology (1986)